Novartis Investigative Site

Sendai

0 studies enrolling now · 2 studies all time

What they study most

Non-Small Cell Lung Cancer, Pulmonary Arterial Hypertension

Studies at this site

• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• Imatinib (QTI571) in Pulmonary Arterial Hypertension — Completed